Buprenorphine for the Treatment of Opioid Use Disorder: A Patient-Centered and Harm Reductionist Approach
CE Information
1.0 CE credit (1.0 pharmacology)Completion Time
1 hour
Navigate
Overview
Specialties
Psychiatric / Mental HealthSubspecialties
Other and Primary CareClinical Topics
PharmacologyThis course will provide an overview of pharmacotherapy for opioid use disorder, with a focus on buprenorphine. Current epidemiology related to opioid use disorder will be discussed, with clinical pearls provided related to best practices in pharmacotherapy. Utilization of a patient-centered and harm reductionist approach will also be covered, with an introduction to motivational interviewing.
- Verbalize current epidemiology of opioid use disorders
- Discuss best practices related to pharmacotherapy for opioid use disorder
- Utilize motivational interviewing techniques
Learning Objectives
- Verbalize current epidemiology of opioid use disorders
- Discuss best practices related to pharmacotherapy for opioid use disorder
- Utilize motivational interviewing techniques
Speakers
Assistant Professor of Nursing at the University of Pittsburgh
Dr. Brayden Kameg currently serves as an Assistant Professor of Nursing in the Department of Health and Community Systems, where she coordinates the psychiatric-mental health nurse practitioner (PMHNP) program. She currently teaches across undergraduate and graduate programs. Her primary teaching responsibilities include family therapy, psychopharmacology, and psychiatric management in primary care. Additionally, she serves as the clinical course coordinator for the undergraduate psychiatric-mental health nursing course. Dr. Kameg’s academic interests include integrating substance use and mental-health-related competencies across undergraduate and graduate programs. She has received extramural funding through the Health Resources and Services Administration (HRSA), Substance Abuse and Mental Health Services Administration (SAMHSA), and the National Institute on Drug Abuse. This funding has supported her work which seeks to improve the ability of both nurses and nurse practitioners to meet the mental and behavioral healthcare needs of the populations that they serve.
CE Information
This activity offers 1.0 CE credit (1.0 pharmacology) to attendees.
Accredited by Provider approved by the California Board of Registered Nursing, Provider # 17810.
This course will provide an overview of pharmacotherapy for opioid use disorder, with a focus on buprenorphine. Current epidemiology related to opioid use disorder will be discussed, with clinical pearls provided related to best practices in pharmacotherapy. Utilization of a patient-centered and harm reductionist approach will also be covered, with an introduction to motivational interviewing.
- Verbalize current epidemiology of opioid use disorders
- Discuss best practices related to pharmacotherapy for opioid use disorder
- Utilize motivational interviewing techniques
Disclosures
None
Activity Content
Registration to this activity includes access to the following supporting materials.
- Slides (Size: 5.42 MB)
Duration: about 1 hour | Quality: HD
6 questions
3 questions | 2 correct test question required to pass
Access your certificate
Register For This Activity
Non-Member Registration
This course will provide an overview of pharmacotherapy for opioid use disorder, with a focus on buprenorphine. Current epidemiology related to opioid use disorder will be discussed, with clinical pearls provided related to best practices in pharmacotherapy. Utilization of a patient-centered and harm reductionist approach will also be covered, with an introduction to motivational interviewing.
APMHNP Members
This course will provide an overview of pharmacotherapy for opioid use disorder, with a focus on buprenorphine. Current epidemiology related to opioid use disorder will be discussed, with clinical pearls provided related to best practices in pharmacotherapy. Utilization of a patient-centered and harm reductionist approach will also be covered, with an introduction to motivational interviewing.